Old Bridge Medicaid COVID-19 claims totaled $8,376 in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

In Old Bridge, Medicaid payments amounted to at least $8,376 in 2024 for services billed under HCPCS codes explicitly designated for COVID-19, based on figures from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a publicly run health insurance initiative administered by the states and financed by both federal and state governments. The program serves low-income people and families, older adults, children, and those with disabilities, making it a major segment of the U.S. health system.

Since taxpayer dollars fund Medicaid payments, shifts in local billing amounts demonstrate how health care funding is distributed within each community.

This analysis identifies COVID-19–related services through HCPCS codes marked or described as “COVID-19” or “coronavirus”-related in billing records or supporting data. The totals reflect only services directly classified as COVID-19 related in billing and may not include all pandemic-linked care billed under broader or alternative medical codes.

For context, Clifton led New Jersey in Medicaid payments tied to COVID-19 in 2024, with virus-related claims totaling $1,725,516.

In 2024, three providers in Old Bridge filed Medicaid claims for COVID-19–related services. Among the codes generating the highest claims was Immunoassay, accounting for $8,063.

The average Medicaid payment per provider for COVID-19–linked services in Old Bridge was $2,792, notably less than the state’s average of $33,367.

During the pandemic, COVID-19–specific services contributed substantially to rises in Medicaid spending in Old Bridge.

From 2020 to 2024, total Medicaid payments for all other claim categories grew by $628,020, which marks a 7.6% rise.

In the two years before the pandemic, annual average Medicaid payments in Old Bridge were $9,324,040.

The Centers for Medicare & Medicaid Services reports that joint federal and state Medicaid spending was about $871.7 billion in fiscal 2023, around 18% of the nation’s health expenditures, compared with $613.5 billion in 2019 prior to the COVID-19 pandemic.

This reflects an increase of approximately 40% over a few years, largely driven by increased enrollment and health care use during and after the pandemic period.

Recent federal budget measures under the Trump administration have proposed major cuts to federal Medicaid funding and changes to the program structure. The “One Big Beautiful Bill Act,” signed in 2025, is set to reduce federal Medicaid spending by over $1 trillion during the next decade and introduces work requirements and higher cost-sharing, which could curtail coverage and funding for certain recipients. These adjustments are anticipated to increase states’ financial responsibility and restrict federal Medicaid expansion, even as the program continues to cover tens of millions of Americans.

Medicaid Payments in Old Bridge Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $8,376 -99.7% $8,864,181
2023 $2,581,446 -61.6% $13,870,661
2022 $6,727,608 152.5% $17,364,910
2021 $2,663,994 7,919.4% $13,008,341
2020 $33,219 N/A $8,261,005
2019 $0 N/A $10,281,512
2018 $0 N/A $8,366,569
Top COVID-19–Related HCPCS Codes in Old Bridge
HCPCS Code Description Medicaid Payments Claims
87811 Immunoassay $8,063 256
U0002 COVID Specific $312 90
87635 COVID Specific $0 259

Note: Includes HCPCS codes exclusively marked for COVID-19 services; totals do not encompass all pandemic-related health care expenses.

The information in this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Access the source data here.



Related

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA inspects Roshen USA, CORP in Cranbury on April 3 for food safety concerns

The Food and Drug Administration conducted an inspection at Roshen USA, CORP in Cranbury on April 3 to assess controls over foodborne biological hazards, according to agency records.

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

FDA conducts April 7 inspection at Easterseals of New Jersey in New Brunswick

The Food and Drug Administration carried out an inspection at Easterseals of New Jersey in New Brunswick on April 7, focusing on foodborne biological hazards, according to the FDA’s online records.

George Murray, Mayor at Borough of Milltown

Milltown dedicates street sign to honor crossing guard Carma Bieglecki

Milltown officials held a ceremony honoring Carma Bieglecki’s forty-two years as a crossing guard by dedicating a street sign at the site where she served generations of students. The tribute recognizes her accident-free career and enduring legacy.